CytoDyn Inc. announced the appointment of Anthony D. Caracciolo as Executive Chairman of CytoDyn effective immediately. In this new capacity, Mr. Caracciolo will assume an active leadership role in the company’s strategic planning, business development and operations. Nader Pourhassan, Ph.D., will continue to serve as President and Chief Executive Officer, and Mr. Caracciolo will retain his position as Chairman of the Board. Mr. Caracciolo has served as CytoDyn’s Chairman of the Board since June 2013 and Director since December 2011. He has more than 38 years of experience in the pharmaceutical sciences industry. Previously, he served for 13 years at Gilead Sciences Inc., prior to his retirement in 2010.  Among his positions at Gilead, he was Senior Vice President, Manufacturing and Operations, and a senior member of that company’s executive committee.